Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
113.48
-0.43 (-0.38%)
Jan 17, 2025, 4:00 PM EST - Market closed
Abbott Laboratories Revenue by Segment
History
| Date | Medical Devices | Diagnostics | Nutrition | Established Pharmaceuticals | Other |
|---|---|---|---|---|---|
| Sep 30, 2024 | 18.38B | 9.36B | 8.32B | 5.15B | 15.00M |
| Jun 30, 2024 | 17.88B | 9.39B | 8.33B | 5.11B | 15.00M |
| Mar 31, 2024 | 17.44B | 9.51B | 8.26B | 5.10B | 14.00M |
| Dec 31, 2023 | 16.89B | 9.99B | 8.15B | 5.07B | 14.00M |
| Sep 30, 2023 | 16.19B | 10.76B | 7.93B | 5.06B | 13.00M |
| Jun 30, 2023 | 15.56B | 11.98B | 7.66B | 5.02B | 12.00M |
| Mar 31, 2023 | 15.02B | 13.99B | 7.53B | 4.95B | 11.00M |
| Dec 31, 2022 | 14.69B | 16.58B | 7.46B | 4.91B | 11.00M |
| Sep 30, 2022 | 14.69B | 17.75B | 7.68B | 4.90B | 11.00M |
| Jun 30, 2022 | 14.70B | 17.99B | 8.00B | 4.84B | 19.00M |
| Mar 31, 2022 | 14.61B | 16.92B | 8.15B | 4.80B | 39.00M |
| Dec 31, 2021 | 14.37B | 15.64B | 8.29B | 4.72B | 52.00M |
| Sep 30, 2021 | 13.88B | 15.52B | 8.19B | 4.66B | 65.00M |
| Jun 30, 2021 | 13.41B | 14.25B | 8.00B | 4.50B | 74.00M |
| Mar 31, 2021 | 12.17B | 12.99B | 7.78B | 4.33B | 67.00M |
| Dec 31, 2020 | 11.79B | 10.81B | 7.65B | 4.30B | 66.00M |
| Sep 30, 2020 | 11.73B | 8.52B | 7.58B | 4.33B | 60.00M |
| Jun 30, 2020 | 11.63B | 7.79B | 7.53B | 4.44B | 56.00M |
| Mar 31, 2020 | 12.28B | 7.70B | 7.52B | 4.54B | 57.00M |
| Dec 31, 2019 | 12.24B | 7.71B | 7.41B | 4.49B | 57.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.